Information needs of cancer survivors vary over time and by cancer type
the ONA take:
Cancer survivors' information needs differed over time depending on the topic, and these trends varied by cancer type, according to a recent study published online ahead of print in the journal Cancer Epidemiology, Biomarkers & Prevention.
For the study, researchers sought to describe how cancer survivors' information needs about late effects, recurrence, and family risks of cancer change over their survivorship period.
Researchers conducted three surveys annually from 2006 to 2008 in cancer survivors diagnosed with breast, colon, or prostate cancer in Pennsylvania. In the first year, 2,013 survivors completed the survey, followed by 1,293 in year 2, and 1,128 in year 3.
Results showed that survivors most frequently sought information about reducing risks of cancer recurrence over all 3 years. Researchers found that breast cancer survivors in particular were more likely to seek information about survivorship topics in the first year than other survivors.
The study demonstrated a sharp decline in information seeking among breast cancer survivors, while female colon cancer survivors sought more information over time. They specifically sought information regarding reducing the risk of family members getting cancer.
The findings suggest that clinicians should be aware that cancer survivors' information needs change over time, and that they may need to intervene at certain points with information to address patient concerns.
Cancer survivors' information needs differed over time depending on the topic, and these trends varied by cancer type.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|